Encube Ethicals Plans $400 Million IPO in Mumbai

Encube Ethicals, supported by private equity firm Quadria Capital, is contemplating an initial public offering (IPO) in Mumbai, aiming to raise approximately $400 million. Bloomberg posted on X, citing sources familiar with the matter, that the pharmaceutical company is evaluating the potential IPO as part of its growth strategy. Encube Ethicals specializes in manufacturing topical formulations and has been expanding its operations to meet increasing demand. The company is reportedly working with advisors to assess market conditions and finalize the details of the offering. The move comes amid a favorable environment for IPOs in India, with several companies seeking to capitalize on investor interest. Encube Ethicals' decision to pursue an IPO reflects its ambition to enhance its market presence and financial standing.